摘要
【目的】构建人神经营养素-3(neurotrophin-3,NT-3)受体(即酪氨酸蛋白激酶受体C,tyrosineproteinkinaseC,TrkC)基因重组的腺病毒表达载体。【方法】从人脑组织mRNA中扩增TrkC基因全长cDNA,定向克隆于穿梭质粒pShuttle中,获得一个带有CMV启动子的表达盒。再将表达盒与腺病毒骨架DNA(Adeno-XviralDNA)体外连接,形成重组腺病毒质粒(pAd-TrkC)。用pAd-TrkC转染人胚肾293细胞后包装成有感染能力的重组腺病毒颗粒(Adeno-TrkC)。【结果】TrkC基因RT-PCR扩增产物为2478bp。Adeno-TrkC经PCR鉴定为正确重组子。【结论】应用体外连接法已构建了人TrkC重组腺病毒表达载体,这为进一步应用NT-3进行基因治疗中枢神经损伤奠定了基础。
[ Objective ] To construct a recombinant adenovirus expression vector carrying human neurotrophin-3 (NT-3) receptor TrkC gene. [Methods] The mRNA were extracted from human brain tissue and the full-length cDNA of human TrkC gene was amplified by reverse transcription polymerase chain reaction (RT-PCR). Firstly, an expression cassette with CMV promoter was made by cloning NT-3 into pShuttle vector. Secondly, the expression cassette was hgated to Adeno-X viral DNA to form a recombinant adenoviral plasmid (pAd-TrkC), which was packaged into infectious recombinant adenoviral particles (Adeno-TrkC) by transfecting human embryonic kidney 293 cells. [Results] The amplified TrkC gene was 2 478 bp in length; Adeno-TrkC was proved to be correct by PCR. [Conclusion] A recombinant adenovirus carrying TrkC was constructed successfully by in vitro ligation reaction, which may provide the basis for using NT-3 in gene therapy.
出处
《中山大学学报(医学科学版)》
CAS
CSCD
北大核心
2005年第5期493-497,共5页
Journal of Sun Yat-Sen University:Medical Sciences
基金
国家重点基础研究发展规划基金资助项目(G1999054009)
国家自然科学基金资助项目(30270700)
广东省社会发展攻关基金资助项目(2003C33808)